Sejong-si, South Korea

Jong Shik Park

USPTO Granted Patents = 1 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jong Shik Park in Antibody Fc Variants

Introduction

Jong Shik Park is an accomplished inventor based in Sejong-si, South Korea, known for his innovative contributions to the field of antibody engineering. His notable patent centers around improving the efficacy of therapeutic antibodies through the development of specific Fc variants that increase their blood half-life, which has significant implications for cancer treatment and various diagnostic applications.

Latest Patents

Jong Shik Park holds a patent titled "Antibody Fc Variants for Increased Blood Half-Life." The invention involves a polypeptide that includes an Fc variant created by substituting portions of the amino acid sequence of the Fc domain of a human antibody. This innovative approach not only enhances the in vivo half-life of antibodies but also opens up potential applications across a wide spectrum of antibodies and Fc-fusion constructs. These constructs can either serve as therapeutic agents to target and kill cancer cells or be employed to modulate the activity of specific antigens.

Career Highlights

Throughout his career, Jong Shik Park has collaborated with notable institutions, including Kookmin University and Osong Medical Innovation Foundation. His work has focused extensively on harnessing the therapeutic potential of antibodies to facilitate better patient outcomes in cancer treatment through optimized Fc variants.

Collaborations

Jong Shik Park has had the opportunity to work with talented colleagues in the field, including Sang Taek Jung and Sanghwan Ko. These collaborations underline his commitment to advancing scientific research and the development of innovative medical solutions.

Conclusion

Jong Shik Park's contributions, particularly through his pioneering patent on antibody Fc variants, showcase the impact of innovative research on the treatment of diseases like cancer. His work not only advances the science of immunotherapy but also stands as a testament to the importance of collaboration in the pursuit of groundbreaking medical technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…